From pumps to prevention: recent advances in the treatment of type 1 diabetes.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drug Discovery Today

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.drudis.2009.06.011PMID 19580883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomized controlled trial

  2010cited by this paper
• Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta‐analysis of randomized control trials

  2009cited by this paper
• Benefits of a bolus calculator in pre‐ and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII)

  2008cited by this paper
• Exendin-4 modulates diabetes onset in nonobese diabetic mice.

  2008cited by this paper
• GAD treatment and insulin secretion in recent-onset type 1 diabetes.

  2008cited by this paper
• Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus.

  2008cited by this paper
• Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched‐pair cohort analysis over 3 years

  2008cited by this paper
• Why doctors should worry about preemption.

  2008cited by this paper
• Continuous glucose monitoring and intensive treatment of type 1 diabetes.

  2008cited by this paper
• Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas

  2008cited by this paper
• The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes

  2008cited by this paper
• Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

  2008cited by this paper
• Continuous subcutaneous insulin infusion benefits quality of life in preschool‐age children with type 1 diabetes mellitus

  2007cited by this paper
• The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.

  2007cited by this paper
• A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes

  2007cited by this paper
• Improved Glycemic Control After Long-Term Insulin Pump Use in Pediatric Patients with Type 1 Diabetes

  2007cited by this paper
• Use of Insulin Pump Therapy in the Pediatric Age-Group

  2007cited by this paper
• Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.

  2007cited by this paper
• Basal insulin supplementation in Type 1 diabetic children: A long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin

  2007cited by this paper
• Evaluation of the Effect of Gain on the Meal Response of an Automated Closed-Loop Insulin Delivery System

  2006cited by this paper
• Position Statement: Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes

  2006cited by this paper
• Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.

  2006cited by this paper
• Insulin pumps in pediatric routine care improve long‐term metabolic control without increasing the risk of hypoglycemia

  2006cited by this paper
• Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial

  2006cited by this paper
• Insulin Pump Therapy in Youth With Type 1 Diabetes: A Retrospective Paired Study

  2006cited by this paper
• Thiazolidinedione use and bone loss in older diabetic adults.

  2006cited by this paper
• Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives

  2006cited by this paper
• Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes.

  2006cited by this paper
• The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes

  2006cited by this paper
• Long‐term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4‐year follow‐up

  2006cited by this paper
• Feasibility and Safety of Insulin Pump Therapy in Children Aged 2 to 7 Years With Type 1 Diabetes: A Retrospective Study

  2006cited by this paper
• ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease?

  2005cited by this paper
• Memory of Insulin Pumps and Their Record as a Source of Information About Insulin Therapy in Children and Adolescents with Type 1 Diabetes

  2005cited by this paper
• A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

  2005cited by this paper
• An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes

  2005cited by this paper
• Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.

  2005cited by this paper
• Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

  2005cited by this paper
• Insulin Pump Therapy in Preschool Children with Type 1 Diabetes Mellitus Improves Glycemic Control and Decreases Glucose Excursions and the Risk of Hypoglycemia

  2005cited by this paper
• A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.

  2005cited by this paper
• A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.

  2005cited by this paper
• A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes.

  2005cited by this paper
• Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

  2005cited by this paper
• The effect of rosiglitazone on overweight subjects with type 1 diabetes.

  2005cited by this paper
• Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective

  2005cited by this paper
• BMC Endocrine Disorders BioMed Central

  2004cited by this paper
• Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes.

  2004cited by this paper
• Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes.

  2004cited by this paper
• A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

  2004cited by this paper
• Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

  2004cited by this paper
• Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

  2004cited by this paper
• Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report

  2004cited by this paper
• A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

  2004cited by this paper
• European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.

  2004cited by this paper
• Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy.

  2004cited by this paper
• Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.

  2003cited by this paper
• Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity.

  2003cited by this paper
• Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

  2003cited by this paper
• Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Diabetes Mellitus: Decreased HbA1c with Low Risk of Hypoglycemia

  2003cited by this paper
• Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT)

  2003cited by this paper
• Performance assessment of the Medtronic‐MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects

  2003cited by this paper
• Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT)

  2003cited by this paper
• Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.

  2003cited by this paper
• Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.

  2003cited by this paper
• Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.

  2003cited by this paper
• Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes.

  2003cited by this paper
• Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups

  2002cited by this paper
• Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus.

  2002cited by this paper
• A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.

  2002cited by this paper
• A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

  2002cited by this paper
• Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

  2002cited by this paper
• Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care.

  2001cited by this paper
• Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.

  2001cited by this paper
• Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.

  1999cited by this paper
• Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.

  1999cited by this paper
• The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.

  1999cited by this paper
• Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

  1992cited by this paper
• Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism.

  1991cited by this paper
• Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.

  1988cited by this paper
• Factors associated with early remission of type I diabetes in children treated with cyclosporine.

  1988cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.

  1979cited by this paper
• Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

  1978cited by this paper

• Comparison of the Sensor-Augmented Pump System with the Advanced Hybrid Closed-Loop delivery System: Quality of Life, Diabetes Distress, and Glycaemic Outcomes in a Real-Life Context.

  2023cites this paper
• Diabetes Mellitus Type 1 During the COVID 19: Psychological Symptoms and Eating Attitudes.

  2022cites this paper
• Safety

  2021cites this paper
• Intersecting Health Policy and the Social Determinants of Health in Pediatric Type 1 Diabetes Management and Care.

  2017cites this paper
• Executive functioning and self-management in adolescents with Type 1 diabetes

  2016cites this paper
• Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries

  2015cites this paper
• Challenges and recent progress in the development of a closed-loop artificial pancreas

  2012cites this paper
• A cross-sectional study of vitamin D, glycemic control, and inflammatory cytokines in children and adolescents with type 1 diabetes mellitus

  2011cites this paper
• The educational implications of type i diabetes mellitus: A review of research and recommendations for school psychological practice

  2011cites this paper
• The Pediatric Diabetes Consortium: Improving Care of Children with Type 1 Diabetes Through Collaborative Research

  2010cites this paper
• Management of type 1 diabetes mellitus

  2010cites this paper
• Biosensor technology in the treatment of cardiovascular disease

  2010cites this paper
• The role of T-lymphocyte repertoire selection in autoimmune diseases

  2009cites this paper
• The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes

  2008cites this paper